Metastatic Prostate Cancer
Showing 9976 - 10000 of >10,000
Locally Advanced or Metastatic Solid Tumors Trial in Guangzhou (Drug: BC3195 for Injection)
Recruiting
- Locally Advanced or Metastatic Solid Tumors
- Drug: BC3195 for Injection
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Jul 20, 2023
Simulation-Based Enucleation Training: Initial Experience Using
Completed
- BPH
- Organ phantom of prostate
-
Montréal, CanadaCentre hospitalier de l'Université de Montréal
Nov 16, 2022
CNS Brain Metastases, Head Neck Cancer, Lung Cancer Trial in Madison (PET-imaging with CuATSM, PET Imaging, PET CuATSM)
Terminated
- CNS Brain Metastases
- +4 more
- PET-imaging with CuATSM
- +4 more
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Dec 12, 2019
Ovarian Tumors Trial in Chongqing
Recruiting
- Ovarian Neoplasms
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Mar 12, 2022
TRAcking Non-small Cell Lung Cancer Evolution Through Therapy
Recruiting
- Non-small Cell Lung Cancer
-
Harlow, Essex, United Kingdom
- +17 more
Feb 22, 2022
Triple-negative Breast Cancer Trial in Shanghai (choline, anti-PD-1 antibody and chemo, Sodium Cromoglicate)
Recruiting
- Triple-negative Breast Cancer
- Choline
- +3 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 29, 2022
Esophageal Cancer, Intensity-modulated Radiation Therapy, Concurrent Chemoradiotherapy Trial in Beijing (rhTPO)
Not yet recruiting
- Esophageal Cancer
- +3 more
-
Beijing, Beijing, ChinaDepartment of Radiation Oncology, Cancer Institute and Hospital,
Jul 12, 2023
General Anesthesia and PECS Block Methods on Blood Counts in
Completed
- Breast Cancer
- general anesthesia
- peripheral nerve blocks
-
Ankara, Yenimahalle, TurkeyDr.Abdurrahman Yurtaslan Ankara Oncology Train and Research Hosp
Nov 21, 2023
Colorectal Cancer Trial in Houston (5-FU, Cetuximab, Dasatinib)
Completed
- Colorectal Cancer
- 5-FU
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 26, 2019
Triple Negative Breast Cancer Trial (Sacituzumab govitecan, Pembrolizumab)
Not yet recruiting
- Triple Negative Breast Cancer
- Sacituzumab govitecan
- Pembrolizumab
- (no location specified)
Oct 5, 2023
Colorectal Carcinoma Trial in Austria (endurance exercise, control)
Recruiting
- Colorectal Carcinoma
- endurance exercise
- control
-
Graz, Styria, Austria
- +8 more
May 24, 2022
BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in
Recruiting
- BCLC Stage A Hepatocellular Carcinoma
- +3 more
- 18F-Fluoromisonidazole
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
May 25, 2022
Stress, Cancer Diagnosis, Distress, Emotional Trial in Boston (Smart-3RP, Enhanced Usual Care)
Not yet recruiting
- Stress
- +2 more
- Smart-3RP
- Enhanced Usual Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jan 18, 2023
Rectal Tumors Trial (procedure, drug, diagnostic test)
Not yet recruiting
- Rectal Neoplasms
- Arterial chemoembolization
- +4 more
- (no location specified)
Jun 26, 2022
Colorectal Cancer, Metastatic Colorectal Cancer, Thymalfasin Trial (Radiation therapy, Thymalfasin)
Withdrawn
- Colorectal Cancer
- +2 more
- Radiation therapy
- Thymalfasin
- (no location specified)
Jun 18, 2019
Stage IB Hepatocellular Carcinoma AJCC v8, Stage II Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC
Not yet recruiting
- Stage IB Hepatocellular Carcinoma AJCC v8
- +2 more
- Durvalumab
- Regorafenib
-
Gainesville, Florida
- +3 more
Jun 15, 2022
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, NSCLC Trial in Worldwide (Ramucirumab, MEDI4736)
Completed
- Gastric Cancer
- +3 more
-
Santa Monica, California
- +27 more
Jan 18, 2021
Lung Lesion(s) Requiring Evaluation Trial in Worldwide (Electromagnetic Navigation Bronchoscopy)
Completed
- Lung Lesion(s) Requiring Evaluation
- Electromagnetic Navigation Bronchoscopy
-
Birmingham, Alabama
- +36 more
May 6, 2021
Bladder Urothelial Carcinoma, Stage III Bladder Cancer AJCC v8 Trial in United States (drug, biological, other, radiation)
Recruiting
- Bladder Urothelial Carcinoma
- Stage III Bladder Cancer AJCC v8
- Cisplatin
- +6 more
-
Anchorage, Alaska
- +212 more
Jan 31, 2023
Hormone Naïve Prostate Cancer and Without Comorbidities Treated
Completed
- Advanced Prostate Cancer
- Degarelix
- LHRH agonist (Leuprorelinacetat, Goserelinacetat, Buserelinacetat, Triptorelinacetat)
-
Rottweil, GermanyInvestigational site (there may be other sites in this country)
Jul 1, 2019
Androgen-insensitive Prostate Cancer Trial in United States (MVA-BN-PRO)
Completed
- Androgen-insensitive Prostate Cancer
- MVA-BN-PRO
-
Homewood, Alabama
- +6 more
Mar 12, 2019
Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage
Recruiting
- Clinical Stage I Esophageal Adenocarcinoma AJCC v8
- +66 more
- Carboplatin
- +10 more
-
Phoenix, Arizona
- +76 more
Jan 11, 2023
Children and Adults With Medullary Thyroid Cancer
Recruiting
- Medullary Thyroid Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022
Head and Neck Squamous Cell Carcinoma Trial (Carrilizumab, bevacizumab,capecitabine)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Carrilizumab, bevacizumab,capecitabine
- (no location specified)
Jul 20, 2023